Managing Patients with Multiple Complex Medical Problems
The best next step is to systematically inventory and reconcile all active medical problems and medications at every clinical encounter, then prioritize therapies that simultaneously address multiple conditions while aligning treatment decisions with the patient's core values and functional goals. 1
Immediate Systematic Assessment Steps
1. Problem List Reconciliation
Update the complete problem list including:
- Cardiovascular conditions (coronary disease, cerebrovascular disease, peripheral arterial disease)
- CV risk factors (hypertension, hyperlipidemia, tobacco use)
- Non-cardiovascular problems (cancer, chronic kidney disease, liver disease, cognitive impairment, fall risk, gait instability, incontinence, depression) 1
This must be done at every clinical encounter with the entire care team responsible for updates 1.
2. Comprehensive Medication Reconciliation
Ask patients to physically bring all medications (prescription, over-the-counter, supplements) or a complete list with names, doses, and frequencies to every visit 1. This is critical because EHR medication lists are frequently inaccurate 1.
Check for:
- Prescription errors (omissions, duplications, incorrect dosing)
- Drug-drug interactions using EHR tools 1
- Renal function (eGFR) to determine if dose adjustments are needed 1
- Medication adherence using pharmacy fill data when available 1
- Nonpharmacologic treatments (diet, physical activity, mobility devices, CPAP) 1
3. Active Deprescribing Assessment
Identify medications that:
- Don't match current active problems
- Represent duplicate therapies within the same drug class
- Are potentially harmful given the patient's current status
- Contribute to problematic polypharmacy
- Have uncertain benefit given reduced life expectancy 1
Common pitfall: Stopping medications requires a detailed safety plan. Taper cardiovascular and CNS-acting drugs cautiously, and generally stop only one medication at a time 2.
Strategic Decision-Making Framework
Prioritize Multi-Condition Therapies
Actively seek medications that treat multiple conditions simultaneously with high impact 1:
- SGLT2 inhibitors for heart failure + diabetes + chronic kidney disease
- ACE inhibitors/ARBs for hypertension + heart failure + chronic kidney disease
- Beta-blockers for atrial fibrillation + heart failure + coronary disease
This approach maximizes benefit while minimizing pill burden and treatment complexity 1.
Assess Patient's Core Values and Goals
Before making treatment changes:
- Identify what matters most to the patient (goals, values, preferences)
- Estimate baseline function, quality of life, prognosis, and disease trajectory
- Rank treatment options by which provides greatest benefit with least burden 1
The 2022 ACC Expert Consensus emphasizes that treatment decisions should focus on outcomes the patient values, not just disease-specific metrics 1.
Patient Engagement Process
Use the "Ask-Tell-Ask" approach 1:
- Clinician shares initial thoughts about high-value treatment options
- Patient shares what matters and asks questions
- Re-evaluate decisions together and reach agreement on medication/therapy plan
- Provide patient education about benefits, harms, and uncertainties 1, 2
Critical point: Patients with better understanding of their conditions engage in more healthful behaviors and have improved clinical outcomes 1.
Care Coordination and Support
Establish Clear Coordination
- Schedule and coordinate appointments with other clinicians
- Use EHR interoperability (health information exchange) 1
- Involve family members/caregivers in the care plan 1
- Consider telemedicine/telehealth where appropriate 1
- Leverage community resources for psychosocial support 1
Assign Care Coordination Responsibility
Consider using named care coordinators who can agree on a course of action with patients and caregivers, particularly important during transitions (e.g., moving to care home) 3. The primary clinician or patient-centered medical home should serve as the central coordinator 2.
Monitoring and Follow-Up
Regular Reassessment
- Monitor treatment effects and clinical parameters at follow-up
- Check for nonspecific symptoms as potential indicators of treatment complications (fatigue, drowsiness, falls, confusion, GI symptoms) 3
- Increase frequency of follow-up after treatment changes 3
- Review self-management plans to ensure patients understand their role 3
Post-Discharge Monitoring
Critical caveat: Newly introduced medications during hospitalization may not have reached steady state at discharge. Effectiveness and side effects cannot be properly assessed in hospital, requiring close outpatient follow-up 3.
Implementation Tools
Use Checklists
Checklists are an essential component of safe and reliable care for chronic disease management in the outpatient setting 1. They provide the entire care team (physicians, nurses, pharmacists, medical assistants, dietitians, social workers) a streamlined means to inventory issues consistently 1.
Leverage Technology
- Computerized decision support systems for prescribing (but don't replace clinical judgment) 3
- Patient-held medication plans with specific instructions for usage, including "as needed" dosing details 3
- Remote patient monitoring where appropriate 1
Key Principles to Avoid Common Pitfalls
Avoid fragmented care: The 2023 ACC guidelines emphasize that older adults with multimorbidity face increased likelihood of drug-drug interactions, polypharmacy, side effects, and high costs 1. Simplifying the treatment regimen is a key harm-reduction strategy 1.
Avoid single-disease focus: Clinical practice guidelines typically address single conditions and don't provide sufficient guidance for multimorbidity 1. You must actively integrate care across conditions rather than treating each disease in isolation.
Avoid assuming adherence: Reliance on EHR dispensing data alone is problematic for assessing medication adherence 1. Use multiple data sources and direct patient inquiry.
Avoid liability fears about undertreatment: When reducing polypharmacy and unnecessary interventions, document the shared decision-making process and rationale clearly 2. The focus should be on patient-centered outcomes, not disease-specific metrics alone.